ERBB2 and breast carcinoma: Remarkably, in HER2-enriched tumors (n = 97), including Luminal B HER2+ (n = 86) and HER2-type (n = 11) intrinsic molecular subtypes, and ER-/HER2− (n = 59) breast cancers, a highly significant association was observed.